Dinutuximab OverviewDinutuximab (Ch14.18, tradename Unituxin) and Dinutuximab beta (tradename Isquette) is a monoclonal antibody used as a second-line treatment for children with high-risk neuroblastoma. Each antibody is made of both mouse and human components and targets glycolipid GD2, expressed on neuroblastoma cells and on normal cells of neuroectodermal origin, including the central nervous system and peripheral nerves. They differ in that dinutuximab is manufactured using mouse cells, and dinutuximab bet...
Read more Dinutuximab Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Dinutuximab
Recent Dinutuximab Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Injection: 17.5mg/5ml
Other drugs which contain Dinutuximab or a similar ingredient: (1 result)
- UNITUXIN Dinutuximab